Changing Kidney Allograft Histology Early Posttransplant: Prognostic Implications of 1‐Year Protocol Biopsies

Allograft histology 1 year posttransplant is an independent correlate to long‐term death‐censored graft survival. We assessed prognostic implications of changes in histology first 2 years posttransplant in 938 first kidney recipients, transplanted 1999–2010, followed for 93.4 ± 37.7 months. Compared to implantation biopsies, histology changed posttransplant showing at 1 year that 72.6% of grafts had minor abnormalities (favorable histology), 20.2% unfavorable histology, and 7.2% glomerulonephritis. Compared to favorable, graft survival was reduced in recipients with unfavorable histology (hazards ratio [HR] = 4.79 [3.27–7.00], p < 0.0001) or glomerulonephritis (HR = 5.91 [3.17–11.0], p < 0.0001). Compared to unfavorable, in grafts with favorable histology, failure was most commonly due to death (42% vs. 70%, p < 0.0001) and less commonly due to alloimmune causes (27% vs. 10%, p < 0.0001). In 80% of cases, favorable histology persisted at 2 years. However, de novo 2‐year unfavorable histology (15.3%) or glomerulonephritis (4.7%) related to reduced survival. The proportion of favorable grafts increased during this period (odds ratio = 0.920 [0.871–0.972], p = 0.003, per year) related to fewer DGF, rejections, polyoma‐associated nephropathy (PVAN), and better function. Graft survival also improved (HR = 0.718 [0.550–0.937], p = 0.015) related to better histology and function. Evolution of graft histologic early posttransplant relate to long‐term survival. Avoiding risk factors associated with unfavorable histology relates to improved histology and graft survival.

[1]  G. Jhangri,et al.  A New Diagnostic Algorithm for Antibody‐Mediated Microcirculation Inflammation in Kidney Transplants , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[2]  P. Nickerson,et al.  Evolution and Clinical Pathologic Correlations of De Novo Donor‐Specific HLA Antibody Post Kidney Transplant , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[3]  J. Papadimitriou,et al.  Histologic versus molecular diagnosis of BK polyomavirus-associated nephropathy: a shifting paradigm? , 2006, Clinical journal of the American Society of Nephrology : CJASN.

[4]  D. Rush,et al.  Sequential protocol biopsies in renal transplant patients. Clinico-pathological correlations using the Banff schema. , 1995, Transplantation.

[5]  F. Vincenti,et al.  Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tacrolimus versus cyclosporine , 1998 .

[6]  T. Larson,et al.  Polyomavirus-associated nephropathy risk in kidney transplants: the influence of recipient age and donor gender. , 2007, Kidney international.

[7]  T. Larson,et al.  Comparison of Low Versus High Tacrolimus Levels in Kidney Transplantation: Assessment of Efficacy by Protocol Biopsies , 2007, Transplantation.

[8]  M. Stegall,et al.  The Pathology and Clinical Features of Early Recurrent Membranous Glomerulonephritis , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[9]  B. Myers,et al.  Chronic injury of human renal microvessels with low-dose cyclosporine therapy. , 1988, Transplantation.

[10]  T. Larson,et al.  Kidney Allograft Fibrosis and Atrophy Early After Living Donor Transplantation , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[11]  J. Sellarésa,et al.  Understanding the Causes of Kidney Transplant Failure : The Dominant Role of Antibody-Mediated Rejection and Nonadherence , 2011 .

[12]  M. Stegall,et al.  Kidney Allograft Inflammation and Fibrosis, Causes and Consequences , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[13]  J. Farber,et al.  Transplant glomerulopathy , 2018, Modern Pathology.

[14]  D. Rush,et al.  Sequential protocol biopsies in renal transplant patients: repeated inflammation is associated with impaired graft function at 1 year. , 1995, Transplantation proceedings.

[15]  M. Stegall,et al.  Significance and Implications of Capillaritis During Acute Rejection of Kidney Allografts , 2010, Transplantation.

[16]  M. Stegall,et al.  Transplant Glomerulopathy: Risk and Prognosis Related to Anti-Human Leukocyte Antigen Class II Antibody Levels , 2008, Transplantation.

[17]  E. Condom,et al.  Evaluation of interstitial lesions in well-functioning renal allografts. , 1995, Transplantation proceedings.

[18]  T. Larson,et al.  Predicting Subsequent Decline in Kidney Allograft Function from Early Surveillance Biopsies , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[19]  D. Wishart,et al.  Transplant Glomerulopathy, Late Antibody‐Mediated Rejection and the ABCD Tetrad in Kidney Allograft Biopsies for Cause , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[20]  M. Stegall,et al.  Identifying Specific Causes of Kidney Allograft Loss , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[21]  G. Einecked,et al.  Banff 07 Classification of Renal Allograft Pathology : Updates and Future Directions , 2008 .

[22]  T. Larson,et al.  The Histology of Solitary Renal Allografts at 1 and 5 Years After Transplantation , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[23]  D. Rush,et al.  Banff 2013 Meeting Report: Inclusion of C4d‐Negative Antibody‐Mediated Rejection and Antibody‐Associated Arterial Lesions , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[24]  T. Larson,et al.  Kidney Transplant Function and Histological Clearance of Virus Following Diagnosis of Polyomavirus‐Associated Nephropathy (PVAN) , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[25]  J. Torras,et al.  Subclinical Rejection Associated with Chronic Allograft Nephropathy in Protocol Biopsies as a Risk Factor for Late Graft Loss , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[26]  F. Cosio,et al.  Recurrent membranoproliferative glomerulonephritis after kidney transplantation. , 2010, Kidney international.

[27]  F. Cosio,et al.  Recurrent Idiopathic Membranous Nephropathy After Kidney Transplantation: A Surveillance Biopsy Study , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[28]  F. Cosio,et al.  Recurrent Idiopathic Membranous Nephropathy: Early Diagnosis by Protocol Biopsies and Treatment with Anti‐CD20 Monoclonal Antibodies , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[29]  T. Larson,et al.  Subclinical Rejection in Tacrolimus-Treated Renal Transplant Recipients , 2002, Transplantation.

[30]  D. Rush,et al.  Histological findings in early routine biopsies of stable renal allograft recipients. , 1994, Transplantation.

[31]  J F Burdick,et al.  International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. , 1993, Kidney international.

[32]  P. Terasaki,et al.  Predicting Kidney Graft Failure by HLA Antibodies: a Prospective Trial , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[33]  M. Stegall,et al.  Kidney Allograft Survival After Acute Rejection, the Value of Follow‐Up Biopsies , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[34]  H. E. Hansen,et al.  The Banff 97 working classification of renal allograft pathology. , 1999, Kidney international.

[35]  T. Larson,et al.  Transplant Glomerulopathy: Subclinical Incidence and Association with Alloantibody , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[36]  A. Matas,et al.  Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody‐Mediated Rejection and Nonadherence , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.